SEC Form 4 · accession 0001179110-16-030674
Axogen, Inc. · AXGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Amy McBride Wendell
Director
Period of report
Sep 16, 2016
Accepted (ET)
Oct 13, 2016 · 12:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000805928
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to purchase)F1 | $8.57 | Sep 16, 2016 | A | 25,000 | A | Dec 16, 2016 | Sep 16, 2023 | Common Stock | 25,000 | 25,000 | D |
| Stock Option (right to purchase)F2 | $8.57 | Sep 16, 2016 | A | 3,750 | A | Dec 28, 2016 | Sep 16, 2023 | Common Stock | 3,750 | 3,750 | D |
Explanation of responses
- F1Option grant for joining the Issuer's Board of Directors. Options vest quarterly as to 12.5% of total share amount beginning with the first vesting date on December 16, 2016 and becoming fully vested September 16, 2018 (two years after grant).
- F2Annual option grant for director of Issuer's Board of Directors, pro-rated for joining Board of Directors during annual period. Option vests as to all shares December 28, 2016 in conformity with vesting for such annual director grants.